2026 data FDA MAUDE openFDA

Assay, Glycosylated Hemoglobin

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Assay, Glycosylated Hemoglobin LIGHT-BOOK · MAUDE

#402 of 1000 · 2,919 reports · 2003–2026

  • BOOK 2,919 reports
  • RANK #402 of 1000
  • DEATH 0 death-typed
  • INJ 26 injury-typed
  • MALF 2,822 malfunction
  • SPAN 2003–2026
  • PEAK 2018: 1,911
  • PHOTO System

Nearest event-volume peer: System, Photopheresis, Extracorporeal (4 report gap)

Assay, Glycosylated Hemoglobin sits #402 of 1000 among tracked device types with 2,919 MAUDE reports spanning 2003–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Event-type mix vs corpus

Shares of FDA event_type codes on this device type, compared with the mean across 1,000 device types that have ≥100 MAUDE reports. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 0.9% corpus 30.4% · below corpus mean (-29.5 pp)
  • MALF 96.7% corpus 64.5% · above corpus mean (+32.2 pp)

Lead product-problem code Device Operates Differently Than Expected is 21% of coded problems · Lead manufacturer TOSOH CORPORATION accounts for 87% of manufacturer-tagged reports · Top event location OUTPATIENT DIAGNOSTIC FACILITY is 65% of location-tagged rows .

Assay, Glycosylated Hemoglobin in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Assay, Glycosylated Hemoglobin carries 2,919 MAUDE reports, ranked #402 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 2,822 (96.7%)
Other 52 (1.8%)
Injury 26 (0.9%)
19 (0.7%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,782 (94.2%)
Congenital Anomaly 40 (1.4%)
Death 35 (1.2%)
D 32 (1.1%)
Other 28 (0.9%)
Disability 24 (0.8%)
Required Intervention 4 (0.1%)
Hospitalization 3 (0.1%)
Life Threatening 2 (0.1%)
H 1 (0.0%)
S 1 (0.0%)

Top Product Problems

Device Operates Differently Than Expected 628
Device Operational Issue 465
Device Displays Incorrect Message 442
Device Issue 315
Mechanical Problem 235
Incorrect, Inadequate or Imprecise Result or Readings 155
High Test Results 129
Increase in Pressure 95
Incorrect Or Inadequate Test Results 80
Pressure Problem 72
Decrease in Pressure 63
Use of Device Problem 61
Leak/Splash 44
Computer Software Problem 43
Low Test Results 30
Non Reproducible Results 26
Therapeutic or Diagnostic Output Failure 25
Calibration Problem 15
Output Problem 15
Fluid/Blood Leak 14

Yearly Trend

03
2003: 1
04
2004: 1
06
2006: 3
07
2007: 5
08
2008: 11
09
2009: 15
10
2010: 4
11
2011: 27
12
2012: 51
13
2013: 193
14
2014: 182
15
2015: 64
16
2016: 29
17
2017: 148
18
2018: 1,911
19
2019: 114
20
2020: 13
21
2021: 7
22
2022: 8
23
2023: 27
24
2024: 39
25
2025: 22
26
2026: 44

Related Entities for Assay, Glycosylated Hemoglobin

Event Locations

OUTPATIENT DIAGNOSTIC FACILITY 1,889 (64.7%)
611 (20.9%)
I 229 (7.8%)
OUTPATIENT TREATMENT FACILITY 78 (2.7%)
HOSPITAL 70 (2.4%)
LABORATORY 21 (0.7%)
OTHER 15 (0.5%)
NO INFORMATION 5 (0.2%)
UNKNOWN 1 (0.0%)

Compare TOSOH CORPORATION vs ROCHE DIAGNOSTICS →

Nationwide devices with similar MAUDE profiles

Two openFDA-derived peer sets for Assay, Glycosylated Hemoglobin, both floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (2,919 here).

Similar death-typed counts

Nearest other device types by death-typed report count (0 here), distinct from the volume row.

Disclaimer: MAUDE figures for Assay, Glycosylated Hemoglobin are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Assay, Glycosylated Hemoglobin; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.